{"id":"W2096008082","doi":"10.1186/1710-1492-10-7","title":"Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab","year":2014,"lang":"en","type":"article","venue":"Allergy Asthma and Clinical Immunology","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Omalizumab; Tolerability; Medicine; Food allergy; Oral food challenge; Placebo; Allergy; Allergen; Desensitization (medicine); Internal medicine; Adverse effect; Immunology; Antibody; Immunoglobulin E; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005205697,0.00191845,0.001824734,0.0005419145,0.0008429632,0.0007815753,0.001142769,0.001513448,0.006776545],"category_scores_gemma":[0.003186843,0.0007029736,0.001238659,0.0003556172,0.0008556605,0.0007071024,0.0005400095,0.002227703,0.0009879547],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001142095,"about_ca_system_score_gemma":0.002235426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005296945,"about_ca_topic_score_gemma":0.001093709,"domain_scores_codex":[0.9977351,0.001295264,0.0001318082,0.0002824693,0.0002641972,0.0002911676],"domain_scores_gemma":[0.9973126,0.0005589827,0.0007938012,0.0004483198,0.0004540949,0.0004321955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6969411,0.1581383,0.005146052,0.001007797,0.0006717272,0.0003067178,0.0005105859,0.002933027,0.06935447,0.0003693269,0.005216018,0.05940484],"study_design_scores_gemma":[0.1739582,0.8018541,0.01050795,0.00004495518,0.0002090215,0.0001620131,0.00004494773,0.001012451,0.008646988,0.0001736172,0.003356354,0.00002943314],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9348584,0.0005635584,0.00275707,0.0001829414,0.0001274944,0.0560554,0.002667991,0.0001791484,0.002607998],"genre_scores_gemma":[0.8554152,0.0007154015,0.009977104,0.0007085972,0.0002933666,0.1231881,0.004615685,0.00007762577,0.005008946],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006776545,"threshold_uncertainty_score":0.02753067,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04964551039162127,"score_gpt":0.4152387035204501,"score_spread":0.3655931931288288,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}